Brief: Vaxxas Appoints Former Merck Global Vaccines President David Peacock As CEO
07/01/2026 13:51
Jan 7 (Reuters) - Medical Developments International Ltd MVP.AX: VAXXAS APPOINTS FORMER MERCK GLOBAL VACCINES PRESIDENT DAVID PEACOCK AS CEO Source text: ID:nGNX3hwtkN Further company coverage: MVP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medical Developments International
See all newsMedical Developments International soars on robust quarterly revenue
Brief: Medical Developments International Posts Qtrly Group Revenue A$10.5 Million
Brief: Vaxxas Appoints Former Merck Global Vaccines President David Peacock As CEO
Brief: Medical Developments International Posts Group Revenue For Q1FY26 At A$10.9 MLN
Australia's Medical Developments International gains on quarterly revenue growth